undefined undefined
NaN.000
NaN.00%
AEON Biopharma (AEON) has shared an update. AEON has halted its Phase 2 study a...
今天 04:42
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
05-15 23:20
AEON Biopharma, Inc. press release (NYSE:AEON): Q1 GAAP EPS of -$3.17. More on AEON Biopharma, Inc. Seeking Alpha’s Quant Rating on AEON Biopharma, Inc. Historical earnings data for AEON Biopharma, In...
05-15 21:50
AEON Biopharma (AMEX:AEON) reported quarterly losses of $(3.17) per share which missed the analyst consensus estimate of $(0.31) by 922.58 percent.
05-15 04:29
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaini...
05-04 02:30
Preliminary results of AEON Biopharma's Phase 2 trial for chronic migraine treatment reveal no significant improvement over placebo. Despite anticipated reductions in monthly migraine days, statistical significance was not reached, prompting a review of development strategies and financial measures.
05-04 01:11
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gai...
05-04 00:49
U.S. stock index futures on Friday surged, after the latest nonfarm payrolls report came in much cooler than expected and pointed to some relief in the labor market. Here are some stocks to watch on F...
05-03 21:16
Losers: AEON Biopharma (AEON) -46% announces preliminary top-line results from phase 2 interim analysis of ABP-450 in the preventive treatment of chronic migraine. Sprout Social (SPT) -29% after Q1 ea...
05-03 20:36
Gainers Helius Medical Tech (NASDAQ:HSDT) shares increased by 48.9% to $3.96 d...
05-03 20:06